Skip to content

Nasal vs Oral Breathing in Drug Induced Sleep vs Natural Sleep

The Impact of Nasal Versus Oral Breathing on Measures of Drug-Induced Sleep Endoscopy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06789770
Acronym
Nasal vs Oral
Enrollment
50
Registered
2025-01-23
Start date
2024-11-20
Completion date
2026-12-01
Last updated
2026-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea, Obstructive

Keywords

breathing route, OSA, nasal breathing, oral breathing

Brief summary

This project will provide important new information regarding (1) the relationship between route of breathing and airway collapsibility and (2) whether route of breathing during DISE (Drug-Induced Sleep Endoscopy) is representative of natural sleep.

Detailed description

As part of standard of care, a drug-induced sleep endoscopy will be done, where route of breathing will be determined as a percentage of total breaths (during baseline, lateral sleep and maneuver). As part of the research procedure, an in-laboratory Polysomnogram will be conducted as study procedure including a oronasal pressure signal cannula to assess route of breathing.

Interventions

None listed

Sponsors

University of Pennsylvania
Lead SponsorOTHER
McCabe Fund
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* • Adults (≥ 18yrs) that underwent clinical evaluation at the CPAP Alternatives Clinic at Penn Otorhinolaryngology. * Must have at least mild OSA (AHI\>5)

Exclusion criteria

* • Sleep study with an AHI\<5, \>25% of total events being central or mixed events, or inability to achieve adequate drug-induced sleep. * Upper Respiratory Illness at the time of the DISE.

Design outcomes

Primary

MeasureTime frameDescription
Classification of route of breathing and upper airway collapsibility during Drug-induced Sleep Endoscopy (DISE)Within 3 months of enrollmentParticipants will be classified as oral breathers if more than 50% of their total breaths during DISE occur through the oral route; otherwise, they will be classified as nasal breathers. The pattern of upper airway collapse will be characterized using the VOTE classification system, a standardized DISE scoring tool assessing the Velum (V), Oropharynx (O), Tongue Base (T), and Epiglottis (E). Each anatomical site is graded on a 0-2 scale, where 0 = no obstruction, 1 = partial obstruction, and 2 = complete obstruction. This outcome assesses relationships between breathing route classification and the anatomical pattern and severity of upper airway collapse

Secondary

MeasureTime frameDescription
Percentage of Oral, Nasal, and Mixed Breathing during DISE and Polysomnography (PSG)Within 3 months of enrollmentFor each participant, every breath within the analysis window will be classified as oral, nasal, or mixed-approximately 5 minutes of stable breathing during DISE and ≥4 hours during overnight polysomnography (PSG). The primary output will be the percentage of breaths in each category for both modalities. Agreement between DISE-based and PSG-based breathing-route classification will be evaluated using statistical agreement methods (e.g., Bland-Altman analyses, concordance metrics).

Countries

United States

Contacts

CONTACTEverett Seay
seaye@pennmedicine.upenn.edu215-662-2777
CONTACTMichael Nichols
nicholsm@pennmedicine.upenn.edu
PRINCIPAL_INVESTIGATORJulianna Rodin, MD

University of Pennsylvania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026